Bryce Seifert, Ph.D., Laboratory Genetics and Genomics Fellow at Duke University School of Medicine is the recipient of the 2019 Richard King Trainee Award
BETHESDA, MD – April 3, 2019 | Bryce Seifert, PhD, Laboratory Genetics and Genomics Fellow at Duke University School of Medicine is the recipient of the 2019 Richard King Trainee Award. This award was instituted by the ACMG Foundation for Genetic and Genomic Medicine to encourage ABMGG, international equivalents or genetic counseling trainees in their careers and to foster the publication of the highest quality research in ACMG’s peer-reviewed journal, Genetics in Medicine (GIM).
Each year the editorial board reviews all articles published in GIM by an ABMGG or genetic counseling trainee who was either a first or corresponding author during that year. The manuscript considered to have the most merit is selected by the editorial board and a cash prize, along with meeting expenses, was awarded at the 2019 ACMG Annual Clinical Genetics Meeting in Seattle, WA.
Dr. Seifert was given the award for his two published articles titled, “Determining the clinical validity of hereditary colorectal cancer and polyposis susceptibility genes using the Clinical Genome Resource Clinical Validity Framework” and “Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panels,” which were published online in December 2018.
Dr. Seifert has specific research interests in hereditary cancer susceptibility, Pompe disease and clinical laboratory test development. He currently serves as a curator on the Clinical Genome Resource’s (ClinGen) Lysosomal Storage Diseases Variant Curation Expert Panel and is a trainee member of both the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP).
“I am both honored and humbled to be the recipient of the 2019 Richard King Award. I wish to thank the ACMG Foundation for recognizing the important work of determining the clinical validity of hereditary cancer susceptibility genes, the researchers and clinicians who publish the evidence that is assessed by curators, and the many individuals involved in the Clinical Genome Resource,” said Dr. Seifert.
Robert Steiner, MD, editor-in-chief of GIM stated, “There was stiff competition indeed this year for the King award, reflecting the very high quality of trainees in our field and the numerous high-quality submissions GIM receives. In the end the editorial board felt that Dr. Seifert was deserving of the award given that he published not one but two outstanding manuscripts in GIM in the previous year, both judged to be highly innovative and impactful.”
The award is given by the ACMG Foundation and is named for Dr. Richard King in recognition of his instrumental role in creating Genetics in Medicine and serving as the first and founding editor-in-chief of the journal.
Eligible trainees include those in the following programs: Clinical Biochemical Genetics; Clinical Cytogenetics; Laboratory Genetics and Genomics; Clinical Molecular Genetics; Combined Internal Medicine/Genetics; Combined Pediatrics/Genetics; PhD Medical Genetics and Genetic Counseling.
The ACMG Foundation for Genetic and Genomic Medicine, a 501(c)(3) nonprofit organization, is a community of supporters and contributors who understand the importance of medical genetics in healthcare. Established in 1992, the ACMG Foundation for Genetic and Genomic Medicine supports the American College of Medical Genetics and Genomics’ mission to “translate genes into health” by raising funds to attract the next generation of medical geneticists and genetic counselors, to sponsor important research, to promote information about medical genetics, and much more.
To learn more about the important mission and projects of the ACMG Foundation for Genetic and Genomic Medicine and how you too can support this great cause, please visit http://www.
Kathy Moran, MBA